American Axle & Manufacturing Holdings, Inc. (NYSE:AXL) Analyst Evaluation

American Axle & Manufacturing Holdings, Inc. (NYSE:AXL) currently has mean rating of 3.00 while 1 analysts have commented the shares as ‘BUY’, 1 recommended as ‘OUTPERFORM’ and 5 commented as ‘HOLD’. The rating score is on a scale of 1-5 where 1 stands for strong buy and 5 stands for strong sell. The mean price target for the equity is at $18.60 while the highest price target suggested by the brokerage firms is $24.00 and low price target is $11.00. The mean price target is calculated keeping in view the consensus of 10 analysts.

The mean revenue estimate for the ongoing quarter ending Dec 16 is $964.87M by 9 analysts. The average forecast of sales for the year ending Dec 16 is $3.97B by 10 financial experts.

American Axle & Manufacturing Holdings, Inc. (NYSE:AXL) went up 4.29% during trading on 01/10/2017, with the company’s shares hitting the price near $19.93. The stock had a trading capacity of 2.18M shares. The firm has a SMA 50 (Simple Moving Average) of 17.67% and a SMA 200-(Simple Moving Average) of 20.84%. This appreciation has taken its market valuation to 1.55B. Shares registered one year high at $20.27 and the one year low of $11.44.

Earnings Summary

In American Axle & Manufacturing Holdings, Inc. (NYSE:AXL) latest quarter ended on 30 Sep 2016, company revealed earnings of $0.78 a share. The reported earnings topped the analyst’s consensus by $0.01 with the surprise factor around 1.30%. In the matter of earnings surprises, it can have a huge impact on a company’s stock price. Several studies suggest that positive earnings surprises not only lead to an immediate hike in a stock’s price, but also to a gradual increase over time.

PharmAthene, Inc. (NYSEMKT:PIP) went up 1.49% during trading on 01/10/2017, closing at $3.40. The stock had a trading capacity of 2.16M shares. The firm has a SMA 50 (Simple Moving Average) of 10.35% and a SMA 200-(Simple Moving Average) of 29.35%. This appreciation has taken its current market value to223.48M and a price-to-earnings ratio to 1.95. Shares registered one year high at $3.40 and the one year low of $1.50.

PharmAthene, Inc. (NYSEMKT:PIP): Stock Appraisals Record

PharmAthene, Inc. (NYSEMKT:PIP) shares currently have a mean rating of 2.00 while 0 analysts have recommended the shares as ‘BUY’, 0 commented as ‘OUTPERFORM’ and 0 commented as ‘HOLD’. The rating score is on a scale of 1-5 where 1 stands for strong buy and 5 stands for sell. The mean price target for the company’s stock is $6.00 while the highest price target suggested by the analysts is $6.00 and low price target is $6.00. The mean price target is calculated keeping in view the consensus of 1 brokerage firms.

PharmAthene, Inc. (NYSEMKT:PIP) has a mean revenue estimate for the ongoing quarter ending Dec 99 of $13.5M, according to 1 analysts. The average forecast of sales for the year ending Dec 16 is $13.5M by 1 analysts.

Earnings Overview For PharmAthene, Inc.

Company latest quarter ended on 30 Sep 2014. There were earnings of $-0.08 per share. The reported earnings missed the analyst’s consensus by $-0.05 with the surprise factor of -166.70%.